EGFR and P-GP Expression in Oropharyngeal Mucosa in Relation to Smoking

About two thirds of head and neck squamous cell carcinoma (HNSCC) cases are attributable to heavy tobacco and alcohol consumption. Tobacco carcinogens cause cellular damage in large areas of the upper aerodigestive tract mucosa and contribute to distinct molecular changes, such as increasing levels...

Full description

Saved in:
Bibliographic Details
Published in:Anticancer research 2012-05, Vol.32 (5), p.1639-1648
Main Authors: BAUMEISTER, Philipp, MÄRTE, Melanie, REITER, Maximilian, WELZ, Christian, SCHWENK-ZIEGER, Sabina, HARREUS, Ulrich
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
ATP-Binding Cassette, Sub-Family B, Member 1 - analysis
ATP-Binding Cassette, Sub-Family B, Member 1 - physiology
Biological and medical sciences
Drug Resistance, Neoplasm
Female
Humans
Male
Medical sciences
Middle Aged
Mucous Membrane - chemistry
Oropharyngeal Neoplasms - virology
Oropharynx - chemistry
Papillomaviridae - isolation & purification
Receptor, Epidermal Growth Factor - analysis
Receptor, Epidermal Growth Factor - physiology
Smoking - metabolism
Tobacco, tobacco smoking
Toxicology
Transforming Growth Factor alpha - pharmacology
Tumors
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:About two thirds of head and neck squamous cell carcinoma (HNSCC) cases are attributable to heavy tobacco and alcohol consumption. Tobacco carcinogens cause cellular damage in large areas of the upper aerodigestive tract mucosa and contribute to distinct molecular changes, such as increasing levels of epidermal growth factor receptor (EGFR), during carcinogenesis. P-Glycoprotein (P-GP) is a multidrug-resistance transporter protein capable of extruding not only cytotoxic drugs, but also certain tobacco-related carcinogens. EGFR plays a major role in the transcriptional and functional regulation of P-GP and previous studies in our laboratory showed that stimulation of EGFR protection protected oropharyngeal cells from a carcinogen that is substrate of P-GP. Therefore, we evaluated expression levels of EGFR and P-GP and looked for a possible association with the smoking status of patients. Tissue cultures of healthy oropharyngeal mucosa were produced from 30 patients undergoing surgery at our Department. Expression levels of EGFR on P-GP were determined by immunohistochemical staining. To evaluate possible influences of EGFR on P-GP expression, we stimulated the receptor using transforming growth factor alpha (TGF-α) for 24, 48 and 72 h. Current and former smokers had significantly higher EGFR/P-GP levels than never smokers. While EGFR expression was detected in almost all samples, P-GP expression was largely restricted to former and current smokers. TGF-α had no detectable effect on EGFR/P-GP levels. These results show an association between tobacco use and levels of both proteins. Since both these proteins are involved in drug resistance of head and neck cancer, this study might help to further understand the differences in response to therapy and prognosis of tobacco-related and -unrelated cancer.
ISSN:0250-7005
1791-7530